BeOne Medicines Ltd. (ONC)
352.83
+4.75
(+1.36%)
USD |
NASDAQ |
Sep 17, 13:42
BeOne Medicines Market Cap : 36.75B for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 36.26B |
| September 15, 2026 | 36.10B |
| September 14, 2026 | 36.86B |
| September 11, 2026 | 36.10B |
| September 10, 2026 | 35.61B |
| September 09, 2026 | 36.56B |
| September 08, 2026 | 36.61B |
| September 04, 2026 | 37.32B |
| September 03, 2026 | 37.78B |
| September 02, 2026 | 37.69B |
| September 01, 2026 | 37.36B |
| August 31, 2026 | 37.46B |
| August 28, 2026 | 38.20B |
| August 27, 2026 | 38.80B |
| August 26, 2026 | 39.15B |
| August 25, 2026 | 39.21B |
| August 24, 2026 | 38.75B |
| August 21, 2026 | 39.01B |
| August 20, 2026 | 38.46B |
| August 19, 2026 | 39.26B |
| August 18, 2026 | 38.45B |
| August 17, 2026 | 37.76B |
| August 14, 2026 | 36.20B |
| August 13, 2026 | 37.09B |
| August 12, 2026 | 37.40B |
| Date | Value |
|---|---|
| August 11, 2026 | 37.43B |
| August 10, 2026 | 37.40B |
| August 07, 2026 | 36.28B |
| August 06, 2026 | 34.36B |
| August 05, 2026 | 34.12B |
| August 04, 2026 | 33.65B |
| August 03, 2026 | 32.69B |
| July 31, 2026 | 32.32B |
| July 30, 2026 | 32.94B |
| July 29, 2026 | 33.46B |
| July 28, 2026 | 33.79B |
| July 27, 2026 | 33.33B |
| July 24, 2026 | 33.33B |
| July 23, 2026 | 33.42B |
| July 22, 2026 | 32.72B |
| July 21, 2026 | 32.59B |
| July 20, 2026 | 31.76B |
| July 17, 2026 | 31.91B |
| July 16, 2026 | 32.46B |
| July 15, 2026 | 31.83B |
| July 14, 2026 | 31.35B |
| July 13, 2026 | 31.08B |
| July 10, 2026 | 30.55B |
| July 09, 2026 | 30.97B |
| July 08, 2026 | 30.87B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Basilea Pharmaceutica AG | 959.99M |
| Santhera Pharmaceuticals Holding AG | 265.06M |
| AC Immune SA | 245.06M |
| CRISPR Therapeutics AG | 5.483B |
| Idorsia Ltd. | 1.618B |
Market Cap Related Metrics
| PE Ratio | 62.00 |
| PS Ratio | 6.624 |
| Price to Book Value | 7.707 |
| Price to Free Cash Flow | 30.53 |
| Price | 352.83 |
| Earnings Yield | 1.61% |
| Operating PE Ratio | 43.99 |
| Normalized PE Ratio | 58.91 |